BUSINESS3 years ago
Skye Biosciences Inc. (OTCMKTS: SKYE) Completes Genotoxicity Studies For Glaucoma Treatment
Skye Biosciences Inc. (OTCMKTS: SKYE) has announced the completion of genotoxicity THCVHS studies necessary to commence its expected Phase 1 clinical trial in Australia. THCVHS for...